# Senti Biosciences Holdings, Inc.: Form 8-K, filed May 14, 2026

- Company: [Senti Biosciences Holdings, Inc.](/companies/snti.md) (CIK 1854270)
- Form: 8-K
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 08:48 ET
- Period: 2026-05-14
- Accession: 0001628280-26-034834
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1854270/000162828026034834/snti-20260514.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1854270/000162828026034834/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1854270/000162828026034834/snti-20260514.htm

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-034834. Last ingested by Listed: Oct 27, 2026, 16:38 ET. No prices; not investment advice.